Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Neuroscience

• Publication date

  1998-04-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0306-4522(97)00604-0PMID 9639285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lamotrigine Reduces Voltage‐Gated Sodium Currents in Rat Central Neurons in Culture

  1997cited by this paper
• Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

  1997cited by this paper
• State-dependent inhibition of Na+ currents by the neuroprotective agent 619C89 in rat hippocampal neurons and in a mammalian cell line expressing rat brain type IIA Na+ channels.

  1996cited by this paper
• Inhibition by riluzole of glycinergic postsynaptic currents in rat hypoglossal motoneurones

  1995cited by this paper
• Na+ channels as targets for neuroprotective drugs.

  1995cited by this paper
• Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

  1994cited by this paper
• Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action

  1994cited by this paper
• A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.

  1994cited by this paper
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

  1993cited by this paper
• The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.

  1993cited by this paper
• Pertussis toxin pretreatment abolishes the inhibitory effect of riluzole and carbachol on D-[3H]aspartate release from cultured cerebellar granule cells.

  1992cited by this paper
• Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.

  1992cited by this paper
• Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

  1992cited by this paper
• Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.

  1991cited by this paper
• Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy.

  1991cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

  1989cited by this paper
• Calcium currents in cultured rat cortical neurons.

  1989cited by this paper
• Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells.

  1989cited by this paper
• Delayed and fast transient potassium currents in rat neocortical neurons in cell culture.

  1988cited by this paper
• Phenytoin: Mechanisms of its anticonvulsant action

  1986cited by this paper
• Pharmacologically distinct glutamate receptors on cerebellar granule cells.

  1986cited by this paper
• Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells.

  1985cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.

  1985cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

  1985cited by this paper
• Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells.

  1984cited by this paper
• Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

  1981cited by this paper
• Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation.

  1978cited by this paper

• Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH‐SY5Y‐ Derived Neurons

  2025cites this paper
• Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents.

  2024cites this paper
• Assessing the efficacy of amyotrophic lateral sclerosis drugs in slowing disease progression: A literature review

  2024cites this paper
• Controlling the Solubility, Release Rate and Permeation of Riluzole with Cyclodextrins

  2024cites this paper
• Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer’s Disease Mice

  2023cites this paper
• A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

  2022cites this paper
• Riluzole partially restores RNA polymerase III complex assembly in cells expressing the leukodystrophy-causative variant POLR3B R103H

  2022cites this paper
• Alternative Targets for Modulators of Mitochondrial Potassium Channels

  2022cites this paper
• Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy

  2022cites this paper
• Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders

  2021cites this paper
• Riluzole: A neuroprotective drug with potential as a novel anti-cancer agent (Review)

  2021cites this paper
• Therapeutic Potential of Sodium Channel Blockers as a Targeted Therapy Approach in KCNA1-Associated Episodic Ataxia and a Comprehensive Review of the Literature

  2021cites this paper
• Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.

  2021cites this paper
• Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy

  2020cites this paper
• Does Riluzole Influence Bone Formation? An in vitro Study of Human Mesenchymal Stromal Cells and Osteoblast.

  2019cites this paper
• Adrenergic agonist induces rhythmic firing in quiescent cardiac preganglionic neurons in nucleus ambiguous via activation of intrinsic membrane excitability

  2019influential citation
• Post-translational Regulation of GLT-1 in Neurological Diseases and Its Potential as an Effective Therapeutic Target

  2019cites this paper
• Effects of Benzothiazolamines on Voltage-Gated Sodium Channels.

  2018cites this paper
• TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole

  2018cites this paper
• Pharmacological modulation of Excitation-Inhibition balance in Autism Spectrum Disorders : a translational approach

  2018cites this paper
• Neuroprotective effect of riluzole in rat model of subarachnoid hemorrhage

  2018cites this paper
• Adrenergic activation of cardiac preganglionic neurons in nucleus ambiguous relies on persistent sodium current

  2018cites this paper
• Prophylactic Riluzole Attenuates Oxidative Stress Damage in Spinal Cord Distraction

  2018cites this paper
• Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents.

  2017cites this paper
• In‐vivo effects of knocking‐down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis

  2017cites this paper
• Riluzole But Not Melatonin Ameliorates Acute Motor Neuron Degeneration and Moderately Inhibits SOD1-Mediated Excitotoxicity Induced Disrupted Mitochondrial Ca2+ Signaling in Amyotrophic Lateral Sclerosis

  2017cites this paper
• Etude des altérations du métabolisme induites par le glutamate dans un modèle in vitro de la sclérose latérale amyotrophique (SLA) par une approche métabolomique

  2016cites this paper
• Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease.

  2016cites this paper
• Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse.

  2016cites this paper
• Locomotor Pattern Generation in Neonatal Rats Contribution of Persistent Sodium Current to

  2015cites this paper
• Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer

  2014cites this paper
• Ionic channel mechanisms mediating the intrinsic excitability of Kenyon cells in the mushroom body of the cricket brain.

  2014cites this paper
• Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice

  2014cites this paper
• Amyotrophic Lateral Sclerosis

  2014cites this paper
• Brivaracetam Differentially Affects Voltage‐Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons

  2014cites this paper
• Progressive Hemorrhagic Necrosis - A Unique Pheno- type of Capillary Fragmentation

  2013cites this paper
• The Sur1-Trpm4 Channel in Spinal Cord Injury.

  2013cites this paper
• Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis.

  2013cites this paper
• Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.

  2013cites this paper
• The Neuroprotective Drug Riluzole Acts via Small Conductance Ca2+-Activated K+ Channels to Ameliorate Defects in Spinal Muscular Atrophy Models

  2013cites this paper
• Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole

  2013cites this paper
• Pacemaker and Plateau Potentials Shape Output of a Developing Locomotor Network

  2012cites this paper
• Metabotropic glutamate receptors (mGluR5) activate transient receptor potential canonical channels to improve the regularity of the respiratory rhythm generated by the pre‐Bötzinger complex in mice

  2012cites this paper
• Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury.

  2012cites this paper
• The Protective Effects of Riluzole on Manganese-Induced Disruption of Glutamate Transporters and Glutamine Synthetase in the Cultured Astrocytes

  2012cites this paper
• Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.

  2012cites this paper
• Rhythmic intrinsic bursting neurons in human neocortex obtained from pediatric patients with epilepsy

  2011cites this paper
• A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?

  2011influential citation
• The role of Rab5a GTPase in endocytosis and post-endocytic trafficking of the hCG-human luteinizing hormone receptor complex

  2011cites this paper
• Elenco delle pubblicazioni

  2010cites this paper
• Riluzole, neuroprotection and amyotrophic lateral sclerosis.

  2010cites this paper
• Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases.

  2010cites this paper
• Activation of glutamate transporters in the locus coeruleus paradoxically activates descending inhibition in rats.

  2010cites this paper
• Differential Mechanisms Of Monoamine-Induced Oscillations In The Lobster Pyloric Pacemaker Neuron

  2010cites this paper
• Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture.

  2010cites this paper
• Potential Therapeutic Strategies for Neurodegenerative Diseases

  2010cites this paper
• Studies of ionic mechanisms in model cell lines of prostate cancer

  2010influential citation
• Differential effects of riluzole on subpopulations of adult rat dorsal root ganglion neurons in vitro.

  2010cites this paper
• Early Excitability Changes in Lumbar Motoneurons of Transgenic SOD1 and SOD1 Mice

  2009cites this paper
• Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice.

  2009cites this paper
• Neurotransmitter evaluation in the hippocampus of rats after intracerebral injection of TsTX scorpion toxin

  2009cites this paper
• Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis.

  2009cites this paper
• Central Administration of Minocycline and Riluzole Prevents Morphine-Induced Tolerance in Rats

  2009cites this paper
• Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure

  2009cites this paper
• Implication of detergent-insoluble aggregates of superoxide dismutase 1 in familial amyotrophic lateral sclerosis

  2009cites this paper
• The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats.

  2009cites this paper
• SKA-31, A New Activator of KCa2 And KCa3.1 Potassium Channels, Potentiates the EDHF Response and Lowers Blood Pressure

  2009cites this paper
• Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1.

  2008cites this paper
• Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.

  2008cites this paper
• Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro

  2008cites this paper
• Major depression: emerging therapeutics.

  2008cites this paper
• Local oscillations of spiking activity in organotypic spinal cord slice cultures

  2008cites this paper
• Riluzole in the Treatment of Mood and Anxiety Disorders

  2008cites this paper
• GABAA receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis

  2008cites this paper
• The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure.

  2007cites this paper
• Anti-glutamatergic effect of riluzole: comparison with valproic acid.

  2007cites this paper
• Contribution of persistent sodium current to locomotor pattern generation in neonatal rats.

  2007cites this paper
• Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

  2007cites this paper
• Persistent Sodium Currents Participate in Fictive Locomotion Generation in Neonatal Mouse Spinal Cord

  2007cites this paper
• Riluzole-induced oscillations in spinal networks.

  2007cites this paper
• Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.

  2006cites this paper
• Modulation of calcium entry and glutamate release in cultured cerebellar granule cells by palytoxin

  2006cites this paper
• Specific regulation of rat glial cell line‐derived neurotrophic factor gene expression by riluzole in C6 glioma cells

  2006cites this paper
• Essential role of the persistent sodium current in spike initiation during slowly rising inputs in mouse spinal neurones

  2006cites this paper
• ANEPIII, a new recombinant neurotoxic polypeptide derived from scorpion peptide, inhibits delayed rectifier, but not A-type potassium currents in rat primary cultured hippocampal and cortical neurons.

  2006cites this paper
• Interaction of Riluzole with the Closed Inactivated State of Kv4.3 Channels

  2006influential citation
• Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?

  2006cites this paper
• The metabotropic glutamate receptor subtype 5 antagonist MPEP and the Na+ channel blocker riluzole show different neuroprotective profiles in reversing behavioral deficits induced by excitotoxic prefrontal cortex lesions.

  2006cites this paper
• Role of persistent sodium current in bursting activity of mouse neocortical networks in vitro.

  2006cites this paper
• Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.

  2005cites this paper
• Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.

  2005cites this paper
• Interactions between riluzole and conventional antiepileptic drugs – a comparison of results obtained in the subthreshold method and isobolographic analysis

  2004cites this paper
• INaP underlies intrinsic spiking and rhythm generation in networks of cultured rat spinal cord neurons

  2004cites this paper
• Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.

  2004cites this paper
• Is the persistent sodium current a specific target of anti-absence drugs?

  2004cites this paper
• Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).

  2004cites this paper
• Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzole

  2004cites this paper
• Differential contribution of pacemaker properties to the generation of respiratory rhythms during normoxia and hypoxia.

  2004cites this paper
• Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease.

  2004cites this paper
• Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation.

  2003cites this paper